Menjugate

Nov 16, 2009 17:02

Furthermore, the percentage of individuals having a rSBA of ≥ 1:8 had fallen from 92% 4-6 weeks after vaccinations to 57% 6 months after immunization with Menjugate®, with the corresponding 4-6 week and 6 month data being 91% and 75% for Meningitec™ and 100% and 86% for NeisVac-C®.Menjugate is the vaccine used in Canada. These are all for ( Read more... )

Leave a comment

Comments 4

smileybabe November 17 2009, 00:00:27 UTC
Wow, that's sad. I've never thought to check the length of effectivness.

Reply

goldoyster November 17 2009, 00:13:56 UTC
I always assumed it was decades or a lifetime but then came across a mention of it and since then (just in the last few weeks or so) have been looking for more info on it, for various vaccines. There is just so much more to them than what the sites for parents provide :(

Reply

goldoyster November 17 2009, 00:14:26 UTC
Do you know what brand they give you in Michigan?

Reply

smileybabe November 18 2009, 01:59:28 UTC
Prevnar

Reply


Leave a comment

Up